However, in younger patients where a stepwise disease is often identified and leads to secondary GBM, this consortium identified the crucial role for IDH metabolic pathways in the genesis of the tumors [7, 12, 52, 54, 72, 78] (Fig. 2). This evidence concerns the gene IDH1 and glioblastoma.